Companies Dominating the Non-opioid Pain Patch Market
- Sanofi S.A.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- GlaxoSmithKline Plc.
- Pfizer Inc.
- Clarion Brands
- Endo Pharmaceuticals
- TEH SENG Pharmaceutical
- Teva Pharmaceutical Industries Ltd.
- Teikoku Seiyaku Co. Ltd.
- Veridian Healthcare
- Sorrento Therapeutics (SCILEX Pharmaceuticals Inc.
Browse Key Market Insights with Data Illustration:
In the News
- GlaxoSmithKline Plc. Received approval from the U.S. Food and Drug Administration for Voltaren Arthritis Pain a nonsteroidal anti-inflammatory drug for the momentary alleviation of arthritis pain, and to enhance public health by expanding the range of medications to the millions of people who experience everyday joint pain from arthritis.
- Scilex Holding Company announced to boost the production of ELYXYB to obtain, and create non-opioid painkillers to deliver fast and long-lasting migraine relief, and also allow doctors an additional tool for managing pain.
